Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Filgrastim for Acute Ischemic Stroke
IRCT20141209020258N63Phase 3Completed
- Sponsor
- Arak University of Medical Sciences
- Start
- Jun 2016
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3 trial of filgrastim in ischemic stroke, sponsored by Arak University of Medical Sciences. Started Jun 2016; status: completed.
02
Drugs
filgrastim
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on IRCT20141209020258N63.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20141209020258N63.